Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 08 Nov 2024 12:47 CET |
HOFSETH BIOCARE | Finansiell kalender | 45102020 Food Products | Annen informasjonspliktig regulatorisk informasjon |
| 08 Nov 2024 12:47 CET |
HOFSETH BIOCARE | Financial calendar | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Nov 2024 08:15 CET |
HOFSETH BIOCARE | Hofseth Biocare ASA: THIRD QUARTER 2024 FINANCIAL REPORT | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Oct 2024 10:55 CEST |
HOFSETH BIOCARE | Hofseth Biocare ASA: CFO RESIGNATION | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Oct 2024 08:45 CEST |
HOFSETH BIOCARE | Hofseth Biocare ASA: HBC IMMUNOLOGY COMPLETES IN VIVO DRUG LEAD STUDIES FOR PROSTATE CANCER TREATMENT | 45102020 Food Products | Inside information |
| 23 Aug 2024 08:00 CEST |
HOFSETH BIOCARE | Hofseth Biocare ASA: SECOND QUARTER AND HALF YEAR 2024 FINANCIAL REPORT | 45102020 Food Products | Half yearly financial reports and audit reports/limited reviews |
| 14 Aug 2024 13:09 CEST |
HOFSETH BIOCARE | Hofseth Biocare ASA: GROUNDBREAKING STUDY REVEALS HOFSETH BIOCARE'S FULL SPECTRUM OMEGAS OMEGO SUPPORTS COVID-19 RECOVERY | 45102020 Food Products | Non-regulatory press releases |
| 02 Jul 2024 09:00 CEST |
HOFSETH BIOCARE | Hofseth Biocare ASA: HBC discovers new drug candidate for asthma and transfers it to HBC Immunology Inc. | 45102020 Food Products | Non-regulatory press releases |
| 11 Jun 2024 09:00 CEST |
HOFSETH BIOCARE | Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY | 45102020 Food Products | Non-regulatory press releases |
| 16 May 2024 08:00 CEST |
HOFSETH BIOCARE | Hofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORT | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 10 May 2024 14:30 CEST |
HOFSETH BIOCARE | Hofseth Biocare ASA: Annual General Meeting completed | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 19 Apr 2024 13:00 CEST |
HOFSETH BIOCARE | Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2024 | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 19 Apr 2024 08:00 CEST |
HOFSETH BIOCARE | Hofseth Biocare ASA: HBC ANNUAL REPORT 2023 | 45102020 Food Products | Annual financial and audit Reports |
| 08 Apr 2024 12:15 CEST |
HOFSETH BIOCARE | NOTIFICATION OF MAJOR HOLDINGS | 45102020 Food Products | Major shareholding notifications |
| 05 Apr 2024 18:08 CEST |
HOFSETH BIOCARE | Hofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDING | 45102020 Food Products | Major shareholding notifications |
| 21 Mar 2024 10:40 CET |
HOFSETH BIOCARE | Hofseth Biocare ASA: UPDATED COMPANY PRESENTATION | 45102020 Food Products | Non-regulatory press releases |
| 14 Mar 2024 12:12 CET |
HOFSETH BIOCARE | Hofseth Biocare ASA: CHAIR KRISTIN FJELLBY GRUNG STEPS DOWN | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Feb 2024 08:00 CET |
HOFSETH BIOCARE | Hofseth Biocare ASA: FOURTH QUARTER 2023 AND FULL YEAR FINANCIAL REPORT | 45102020 Food Products | Half yearly financial reports and audit reports/limited reviews |
| 06 Feb 2024 15:56 CET |
HOFSETH BIOCARE | Hofseth Biocare ASA: HBC Immunology Inc successfully completes first animal model of prostate cancer with FT-005 in combination with hormonal (anti-androgen) therapy demonstrating significant anti-tumour activity | 45102020 Food Products | Inside information |
| 09 Jan 2024 12:44 CET |
HOFSETH BIOCARE | Hofseth Biocare ASA: SHARE CAPITAL INCREASE REGISTERED | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Jan 2024 14:02 CET |
HOFSETH BIOCARE | Hofseth Biocare ASA: EXTRAORDINARY GENERAL MEETING CONCLUDED | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Dec 2023 11:29 CET |
HOFSETH BIOCARE | Hofseth Biocare ASA: EGM Notice Correction | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 Dec 2023 13:28 CET |
HOFSETH BIOCARE | Hofseth Biocare ASA: Notice of an extraordinary general meeting | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 13 Dec 2023 22:49 CET |
HOFSETH BIOCARE | Hofseth Biocare ASA: SIGNIFICANT NEW INVESTMENT OF NOK 144 MILLION FROM HOFSETH INTERNATIONAL INTO HBC | 45102020 Food Products | Inside information |
| 27 Nov 2023 12:01 CET |
HOFSETH BIOCARE | Hofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDING | 45102020 Food Products | Major shareholding notifications |
| 27 Nov 2023 11:39 CET |
HOFSETH BIOCARE | Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE | 45102020 Food Products | Mandatory notification of trade primary insiders |
| 13 Nov 2023 15:02 CET |
HOFSETH BIOCARE | Finansiell kalender | 45102020 Food Products | Annen informasjonspliktig regulatorisk informasjon |
| 13 Nov 2023 15:02 CET |
HOFSETH BIOCARE | Financial calendar | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 10 Nov 2023 08:00 CET |
HOFSETH BIOCARE | Hofseth Biocare ASA: THIRD QUARTER 2023 FINANCIAL REPORT | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Aug 2023 08:00 CEST |
HOFSETH BIOCARE | Hofseth Biocare ASA: SECOND QUARTER 2023 FINANCIAL REPORT | 45102020 Food Products | Half yearly financial reports and audit reports/limited reviews |
| 17 Aug 2023 08:58 CEST |
HOFSETH BIOCARE | Hofseth Biocare ASA: SUCCESSFULLY COMPLETED SEED ROUND CAPITAL RAISE IN HBC IMMUNOLOGY LLC AT $20M VALUATION FOR THE DEVELOPMENT OF A NEW PROSTATE CANCER CO-THERAPY | 45102020 Food Products | Inside information |
| 14 Jul 2023 14:33 CEST |
HOFSETH BIOCARE | Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION | 45102020 Food Products | Mandatory notification of trade primary insiders |
| 30 May 2023 08:40 CEST |
HOFSETH BIOCARE | Hofseth Biocare ASA: ADVANCING THE TREATMENT OF PROSTATE CANCER WITH PUBLICATION OF FTH1 RESEARCH ABSTRACT AHEAD OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) MEETING | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 May 2023 07:50 CEST |
HOFSETH BIOCARE | Hofseth Biocare ASA: SPIN-OFF OF PROSTATE CANCER CO-TREATMENT PROJECT | 45102020 Food Products | Inside information |
| 12 May 2023 07:56 CEST |
HOFSETH BIOCARE | Hofseth BioCare ASA: FIRST QUARTER 2023 FINANCIAL REPORT | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Apr 2023 14:09 CEST |
HOFSETH BIOCARE | Hofseth Biocare ASA: COMPLETED ANNUAL GENERAL MEETING | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Apr 2023 11:32 CEST |
HOFSETH BIOCARE | Hofseth Biocare ASA: DISCLOSURE OF VOTING PROXIES | 45102020 Food Products | Total number of voting rights and capital |
| 13 Apr 2023 23:56 CEST |
HOFSETH BIOCARE | Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2023 | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 31 Mar 2023 08:00 CEST |
HOFSETH BIOCARE | Hofseth Biocare ASA: HBC ANNUAL REPORT 2022 | 45102020 Food Products | Annual financial and audit Reports |
| 28 Feb 2023 08:00 CET |
HOFSETH BIOCARE | Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION | 45102020 Food Products | Mandatory notification of trade primary insiders |
| 17 Feb 2023 08:00 CET |
HOFSETH BIOCARE | Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION | 45102020 Food Products | Mandatory notification of trade primary insiders |
| 15 Feb 2023 18:12 CET |
HOFSETH BIOCARE | Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION | 45102020 Food Products | Mandatory notification of trade primary insiders |
| 15 Feb 2023 18:12 CET |
HOFSETH BIOCARE | Hofseth Biocare ASA: | 45102020 Food Products | Meldepliktig handel for primærinnsidere |
| 10 Feb 2023 08:00 CET |
HOFSETH BIOCARE | Hofseth Biocare ASA: FOURTH QUARTER 2022 & FULL YEAR FINANCIAL REPORT | 45102020 Food Products | Half yearly financial reports and audit reports/limited reviews |
| 30 Dec 2022 10:08 CET |
HOFSETH BIOCARE | Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE | 45102020 Food Products | Mandatory notification of trade primary insiders |
| 17 Nov 2022 10:57 CET |
HOFSETH BIOCARE | Financial calendar | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Nov 2022 10:57 CET |
HOFSETH BIOCARE | Finansiell kalender | 45102020 Food Products | Annen informasjonspliktig regulatorisk informasjon |
| 11 Nov 2022 08:00 CET |
HOFSETH BIOCARE | Hofseth Biocare ASA: THIRD QUARTER 2022 FINANCIAL REPORT | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Oct 2022 09:24 CEST |
HOFSETH BIOCARE | Hofseth Biocare ASA: STANFORD SCHOOL OF MEDICINE SUCCESSFULLY COMPLETES PRE-CLINICAL TRIAL WORK TESTING PROGO® BIOACTIVE PEPTIDES IN EFFECTIVE GUT HEALTH SUPPORT | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Aug 2022 14:25 CEST |
HOFSETH BIOCARE | Hofseth Biocare ASA: COMPLETED EXTRAORDINARY GENERAL MEETING | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |